ALFA Filings
Every announcement, straight from the exchange
Every Astec Lifesciences results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Astec LifeSciences released a press release on its Q2 and H1 FY27 results, approved October 26, 2026. Q2 FY27 losses widened year on year.
Astec LifeSciences announced its Q1 FY27 financial results, reporting total income of ₹84.3 crore and an EBITDA of ₹0.1 crore.
Astec LifeSciences reported a 17.1% year-on-year increase in FY26 consolidated total income to ₹453.2 Crore. Despite a loss after tax of ₹80.9 Crore, the company achieved EBITDA breakeven at ₹0.5 Crore. Growth was primarily driven by improved volumes in the Enterprise and CDMO segments.